Physician profile
Ashima Batra
NPI 1275909483
$1,139.87
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $143 · 2023: $715 · 2024: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $997.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $996.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $220.57 | 2022-2024 | Cardiomems |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $130.57 | 2023-2024 | Lifevest |
| Cardiac Dimensions, INC. | $130.26 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $122.51 | 2023-2024 | Camzyos |
| Lexicon Pharmaceuticals, INC. | $88.35 | 2024 | Inpefa |
| Merck Sharp & Dohme LLC | $74.34 | 2023 | Verquvo |
| Pfizer INC. | $70.40 | 2023-2024 | |
| Livanova USA, INC. | $58.64 | 2023 | Lifesparc |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.96 | 2023 | Jardiance |
| Amgen INC. | $43.58 | 2023 | Repatha |
| Novartis Pharmaceuticals Corporation | $42.75 | 2022-2023 | |
| Sanofi-Aventis U.S. LLC | $37.10 | 2023-2024 | |
| Teleflex LLC | $23.13 | 2023 | Manta |
| Philips North America LLC | $20.67 | 2023 | |
| Scpharmaceuticals INC. | $16.34 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $14.70 | 2024 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashima Batra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.